Manhattan Research Report Explores Online Adherence Opportunities for Pharma, Biotech, and Device Manufacturers
The Online Adherence Module provides key insights and data for manufacturers looking to leverage emerging media and technology to increase adherence

June 23, 2009, New York, NY –  Pharmaceutical and healthcare market research company Manhattan Research releases its latest consumer marketing research module, “Online Adherence Programs: Evaluating Manufacturers' Opportunity to Impact Patient Adherence,” as part of its Cybercitizen Health™ market research and strategic advisory service.

The objective of the Online Adherence Module is to provide pharma, biotech, and device marketers with the necessary data and insights to develop their online adherence strategy to increase sales in the face of shrinking pipelines and expiring patents. It gives an in-depth look at the role the Internet plays in how consumers adhere to treatment today, the outlook for consumer demand for online adherence services in the mid-term, and best practices for manufacturers.

According to the analysis, emerging technology, consumer adoption of new media, and an increasing culture of self-service, among other factors, has put the Internet in a prime position to significantly affect patient adherence, treatment outcomes, and ultimately the manufacturer’s bottom line. But along with the opportunities come numerous challenges, especially among certain therapeutic segments, requiring manufacturers implement best practices from the get go. 

“Successful adherence programs can greatly benefit manufacturers, as relatively small changes in patient behavior have the potential to substantially increase revenue,” said Monique Levy, author of the analysis and Senior Director of Research at Manhattan Research. “Though manufacturers have been somewhat reluctant to put all of their weight behind these types of initiatives in the past due to complexity and cost, digital channels are offering new and effective ways to facilitate patient adherence.” 


Analysis Outline

Title: Online Adherence Programs: Evaluating Manufacturers’ Opportunity to Impact Patient Adherence

Introduction 

  • Role of the Internet on Treatment Adherence
    • Figure 1-1: Adoption of Dedicated Adherence Online Resources 
    • Figure 1-2: Occasions When Consumers Perform Online Health Research 
    • Figure 1-3: Shifts in the Digital Health Media Landscape 
    • Figure 1-4:  Adoption of Dedicated Adherence Resources Across Select Therapeutic Segments 
    • Figure 1-5: Occasions in Which Consumers in Different Therapeutic Categories go Online for Health Information 

  • Consumer Demand for Online Adherence Resources in the Mid-term 
    • Figure 2-1:  Interest in Prescription Refill Reminders 
    • Figure 2-2:  Interest in Prescription Refill Reminders Among Online Consumers Who Take Prescription Drugs Across Select Conditions 
    • Figure 2-3: Demand for Health Services on Mobile Devices
    • Figure 2-4:  ePharma Consumer Using or Very Interested in Accessing Information about Prescription Drugs on General Health Sites 
    • Figure 2-5: Drivers and Inhibitors of Online Adherence
    • Close-up 2-1: Johnson & Johnson’s CareConnect iPhone App 

  • Best Practices for Manufacturers 

Key Learnings and Action Items


For an excerpt from the analysis and more information about its contents, please visit: www.manhattanresearch.com/products/Research_Modules/Consumer/online-patient-adherence.aspx


Access to the “Online Adherence Programs” module is immediately available to subscribers of Manhattan Research’s Cybercitizen Health™ v8.0 market research and strategic advisory service. For more information about becoming a subscriber of this service and gaining access to the in-depth consumer market data and analysis, contact sales@manhattanresearch.com, call 1.888.680.0800, ext.2 or visit www.manhattanresearch.com/cch.


About Cybercitizen Health™ v8.0

Cybercitizen Health™ v8.0 was fielded in Q3 2008 among 8,714 U.S. adults (ages 18+). This consumer market research and strategic advisory service focuses on how consumers use new media and technology for health and its impact on treatment and product decisions. For topics and available therapeutic segmentations (100+), please visit www.manhattanresearch.com/cch.   


About Manhattan Research
 
Manhattan Research, a Decision Resources, Inc. company, is a leading market research and advisory services firm for global pharmaceutical and healthcare companies. For more information, visit www.manhattanresearch.com, email sales@manhattanresearch.com or call 1.888.680.0800. 


About Decision Resources, Inc.
 
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.decisionresourcesinc.com.
 

###
 
All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

Media Contact:
Maureen Malloy
mmalloy@manhattanresearch.com
212-255-7799 

| Share on Facebook | Del.icio.us | Digg this | Email This